Conference News

PRISM Trial Update Presented at RWC

Mark Barakat, MD, provided an update on the PRISM clinical trial for 4D-150 (4DMT) for wet AMD at the Retina World Congress meeting in Fort Lauderdale.

Share

  • 1

    Retina World Congress: key event for retina specialists

  • 2

    Focus on latest developments and treatment options for retinal diseases

  • 3

    Aims to foster collaboration and improve patient care

  • 4

    Leading industry experts to share insights

  • 5

    Opportunity for networking and advancing knowledge

Original Source(s)

PRISM Trial Update Presented at RWC

Mark Barakat, MD, provided an update on the PRISM clinical trial for 4D-150 (4DMT) for wet AMD at the Retina World Congress meeting in Fort Lauderdale.

  • by Mark R. Barakat, MD

  • May 1, 2025

  • 3 min

Related Content

Understanding Protocol AO, the DRCR Retina Network’s Study of Home OCT

A conversation with Christina Y. Weng, MD, MBA

Real-World nAMD Treatment Patterns Reveal Cost of Switching

Analysis of Medicare claims show increases in drug-related expenditures after initial low-cost therapy.

Migaldendranib May Move the Needle in AMD, DME

Michael A. Singer, MD, shares early phase 2 data supporting D-4517.2 as a safe and effective subcutaneous therapy, reducing injection burden and preserving vision.